Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993–2020
- 23 February 2021
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 322, 61-66
- https://doi.org/10.1016/j.atherosclerosis.2021.02.022
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genesNetherlands Heart Journal, 2011
- Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade projectClinical Genetics, 2010
- Efficacy of statins in familial hypercholesterolaemia: a long term cohort studyBMJ, 2008
- Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry studyEuropean Heart Journal, 2008
- Diagnosis of Familial Hypercholesterolemia in General Practice Using Clinical Diagnostic Criteria or Genetic Testing as Part of Cascade Genetic ScreeningPublic Health Genomics, 2008
- Update of the molecular basis of familial hypercholesterolemia in The NetherlandsHuman Mutation, 2005
- Cascade genetic screening for familial hypercholesterolemiaClinical Genetics, 2004
- Human Gene Mutation Database (HGMD®): 2003 updateHuman Mutation, 2003
- The inheritance of hyperipoproteinaemia with xanthomatosis:A study of 132 kindredsClinical Genetics, 1976
- Coronary Artery Disease in 116 Kindred with Familial Type II HyperlipoproteinemiaJournal of the American College of Cardiology, 1974